“…The studies ( n = 53) described cases of concurrent Mpox and HIV infection, including the number of cases, HIV infection, history of sexually transmitted diseases, method of Mpox diagnosis, clinical manifestations, location, and progression of skin lesions, CD4+ T-cell count, HIV viral load, treatment, and outcome ( Table 2 and Table 3 ). Table 2 presents a summary of the general features of the publications included in this review [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 ,…”